Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / BIOVF - Swedish Orphan Biovitrum AB (BIOVF) CEO Guido Oelkers on Q1 2022 Results - Earnings Call Transcript

BIOVF - Swedish Orphan Biovitrum AB (BIOVF) CEO Guido Oelkers on Q1 2022 Results - Earnings Call Transcript

Swedish Orphan Biovit Ord
Swedish Orphan Biovitrum AB (BIOVF) Q1 2022 Earnings Conference Call April 28, 2022 07:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Anders Ullman - Head of Research & Development, Chief Medical Officer Armin Reininger - Head of Medical and Scientific Affairs Conference Call Participants Adam Karlsson - ABG Viktor Sundberg - Nordea Peter Östling - Pareto Securities Christopher Uhde - SEB Mattias Häggblom - Handelsbanken Erik Hultgård - Carnegie Adam Karlsson - ABG Eun Yang - Jefferies Christopher Uhde - SEB Caroline Banér - Danske Bank Viktor Sundberg - Nordea Presentation Operator Ladies and gentlemen, welcome to the Sobi Q1 2022 report. Throughout the call, all participants will be in a listen-only mode. And afterwards there will be a question-and-answer session. I will now hand over to the company. Guido Oelkers Yes. Hello, everybody. This is Guido Oelkers, CEO of Sobi.

For further details see:

Swedish Orphan Biovitrum AB (BIOVF) CEO Guido Oelkers on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Swedish Orphan Biovit Ord
Stock Symbol: BIOVF
Market: OTC
Menu
BIOVF BIOVF Quote BIOVF Short BIOVF News BIOVF Articles BIOVF Message Board
Get BIOVF Alerts

News, Short Squeeze, Breakout and More Instantly...